Vital Signs - Sequestration Paints Bleak Outlook for Life Science Research Tools Suppliers

Regular Price: USD 450

Special Price USD 383

15% OFF

* Required Fields

Regular Price: USD 450

Special Price USD 383

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on July 31, 2013, provides an analysis of sequestration measures that were in effect March 1st, 2013 on academic and government laboratory spending on life science research tools and products.

Additionally, a company spotlight is provided for BioScale in Lexington, MA. The company provides a highly innovative protein measurement technology, the ViBE platform, which delivers tremendous advantages in sensitivity, speed, and simple protein assay development.

Table of Contents

Vital Signs - Sequestration Paints Bleak Outlook for Life Science Research Tools SuppliersVital Signs: July 31 2013This week's issue




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.